Acadia Healthcare (ACHC) Projected to Post Earnings on Thursday

Acadia Healthcare (NASDAQ:ACHCGet Free Report) will likely be posting its quarterly earnings results after the market closes on Thursday, February 27th. Analysts expect Acadia Healthcare to post earnings of $0.75 per share and revenue of $778.98 million for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Acadia Healthcare Stock Up 2.6 %

Shares of ACHC stock opened at $40.67 on Tuesday. Acadia Healthcare has a 1 year low of $36.50 and a 1 year high of $87.77. The stock has a market cap of $3.78 billion, a PE ratio of 13.33, a price-to-earnings-growth ratio of 1.50 and a beta of 1.30. The business’s fifty day moving average is $42.13 and its 200-day moving average is $52.59. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.

Analyst Upgrades and Downgrades

ACHC has been the topic of several research analyst reports. Barclays lowered their price target on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research report on Friday, November 22nd. Cantor Fitzgerald restated a “neutral” rating and issued a $52.00 target price on shares of Acadia Healthcare in a report on Tuesday, December 10th. StockNews.com cut Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $64.00 target price on shares of Acadia Healthcare in a research report on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and raised their target price for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $70.22.

Read Our Latest Stock Report on Acadia Healthcare

Acadia Healthcare Company Profile

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Read More

Earnings History for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.